
Addus HomeCare (ADUS) Stock Forecast & Price Target
Addus HomeCare (ADUS) Analyst Ratings
Bulls say
Addus HomeCare is actively investing in technology to improve their services, with the implementation of their next-generation Homecare Homebase (HCHB) platform and caregiver app rollout. The personal care segment has shown consistent organic growth, driven by improved caregiver utilization and scheduling. However, changes in personal care policies and federal regulations could potentially impact their financials. The hospice segment also showed strong organic census growth, but Home Health revenues were below expectations due to lower volumes. Overall, Addus HomeCare is a well-positioned company with a positive outlook for the future, especially if they can successfully integrate their recent acquisition of Gentiva.
Bears say
Addus HomeCare is likely to face challenges in its Personal Care segment as a potential repeal of the 80/20 Medicaid Access rule could negatively impact its access to care and result in lower revenues. The company's recent decline in M&A activity may also hinder its growth potential, despite its strong financial position. Furthermore, potential Medicare moratoriums on new agency enrollment and labor constraints may continue to dampen growth and hinder the company's ability to achieve its target price.
This aggregate rating is based on analysts' research of Addus HomeCare and is not a guaranteed prediction by Public.com or investment advice.
Addus HomeCare (ADUS) Analyst Forecast & Price Prediction
Start investing in Addus HomeCare (ADUS)
Order type
Buy in
Order amount
Est. shares
0 shares